Logo image of ACMR

ACM RESEARCH INC-CLASS A (ACMR) Stock Fundamental Analysis

NASDAQ:ACMR - Nasdaq - US00108J1097 - Common Stock - Currency: USD

24.37  -1.36 (-5.29%)

After market: 24.3701 0 (0%)

Fundamental Rating

5

Overall ACMR gets a fundamental rating of 5 out of 10. We evaluated ACMR against 110 industry peers in the Semiconductors & Semiconductor Equipment industry. ACMR has an average financial health and profitability rating. ACMR is growing strongly while it also seems undervalued. This is an interesting combination


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

In the past year ACMR was profitable.
In the past year ACMR had a positive cash flow from operations.
ACMR had positive earnings in each of the past 5 years.
ACMR had negative operating cash flow in 4 of the past 5 years.
ACMR Yearly Net Income VS EBIT VS OCF VS FCFACMR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

1.2 Ratios

The Return On Assets of ACMR (5.48%) is better than 69.09% of its industry peers.
ACMR has a better Return On Equity (11.17%) than 71.82% of its industry peers.
Looking at the Return On Invested Capital, with a value of 9.29%, ACMR is in the better half of the industry, outperforming 78.18% of the companies in the same industry.
ACMR had an Average Return On Invested Capital over the past 3 years of 7.61%. This is below the industry average of 10.57%.
The 3 year average ROIC (7.61%) for ACMR is below the current ROIC(9.29%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.48%
ROE 11.17%
ROIC 9.29%
ROA(3y)4.65%
ROA(5y)4.61%
ROE(3y)9.12%
ROE(5y)9.25%
ROIC(3y)7.61%
ROIC(5y)6.62%
ACMR Yearly ROA, ROE, ROICACMR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200 300 400 500

1.3 Margins

ACMR's Profit Margin of 13.21% is fine compared to the rest of the industry. ACMR outperforms 70.00% of its industry peers.
ACMR's Profit Margin has declined in the last couple of years.
ACMR's Operating Margin of 18.95% is fine compared to the rest of the industry. ACMR outperforms 75.45% of its industry peers.
ACMR's Operating Margin has improved in the last couple of years.
ACMR's Gross Margin of 49.23% is in line compared to the rest of the industry. ACMR outperforms 58.18% of its industry peers.
In the last couple of years the Gross Margin of ACMR has remained more or less at the same level.
Industry RankSector Rank
OM 18.95%
PM (TTM) 13.21%
GM 49.23%
OM growth 3Y9.03%
OM growth 5Y3.12%
PM growth 3Y-2.96%
PM growth 5Y-5.43%
GM growth 3Y4.22%
GM growth 5Y1.2%
ACMR Yearly Profit, Operating, Gross MarginsACMR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

More info and screens

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ACMR is destroying value.
ACMR has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ACMR has more shares outstanding
ACMR has a worse debt/assets ratio than last year.
ACMR Yearly Shares OutstandingACMR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
ACMR Yearly Total Debt VS Total AssetsACMR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

ACMR has an Altman-Z score of 2.42. This is not the best score and indicates that ACMR is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.42, ACMR is not doing good in the industry: 61.82% of the companies in the same industry are doing better.
The Debt to FCF ratio of ACMR is 2.52, which is a good value as it means it would take ACMR, 2.52 years of fcf income to pay off all of its debts.
ACMR has a Debt to FCF ratio of 2.52. This is in the better half of the industry: ACMR outperforms 64.55% of its industry peers.
A Debt/Equity ratio of 0.17 indicates that ACMR is not too dependend on debt financing.
The Debt to Equity ratio of ACMR (0.17) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 2.52
Altman-Z 2.42
ROIC/WACC0.95
WACC9.77%
ACMR Yearly LT Debt VS Equity VS FCFACMR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

ACMR has a Current Ratio of 2.46. This indicates that ACMR is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of ACMR (2.46) is worse than 63.64% of its industry peers.
A Quick Ratio of 1.49 indicates that ACMR should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.49, ACMR is not doing good in the industry: 73.64% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 2.46
Quick Ratio 1.49
ACMR Yearly Current Assets VS Current LiabilitesACMR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 10.00% over the past year.
ACMR shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 42.35% yearly.
Looking at the last year, ACMR shows a very strong growth in Revenue. The Revenue has grown by 26.21%.
ACMR shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 48.72% yearly.
EPS 1Y (TTM)10%
EPS 3Y52.55%
EPS 5Y42.35%
EPS Q2Q%-11.54%
Revenue 1Y (TTM)26.21%
Revenue growth 3Y44.39%
Revenue growth 5Y48.72%
Sales Q2Q%13.24%

3.2 Future

Based on estimates for the next years, ACMR will show a small growth in Earnings Per Share. The EPS will grow by 2.62% on average per year.
The Revenue is expected to grow by 17.05% on average over the next years. This is quite good.
EPS Next Y1.32%
EPS Next 2Y2.62%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year21.63%
Revenue Next 2Y18.38%
Revenue Next 3Y18.8%
Revenue Next 5Y17.05%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ACMR Yearly Revenue VS EstimatesACMR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
ACMR Yearly EPS VS EstimatesACMR Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 1 1.5 2

More info and screens

7

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 11.08 indicates a reasonable valuation of ACMR.
Based on the Price/Earnings ratio, ACMR is valued cheaply inside the industry as 95.45% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 26.32, ACMR is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 10.24, the valuation of ACMR can be described as reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ACMR indicates a rather cheap valuation: ACMR is cheaper than 93.64% of the companies listed in the same industry.
ACMR is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.13, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 11.08
Fwd PE 10.24
ACMR Price Earnings VS Forward Price EarningsACMR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

92.73% of the companies in the same industry are more expensive than ACMR, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, ACMR is valued cheaply inside the industry as 85.45% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 17.31
EV/EBITDA 7.58
ACMR Per share dataACMR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of ACMR may justify a higher PE ratio.
PEG (NY)8.37
PEG (5Y)0.26
EPS Next 2Y2.62%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ACMR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ACM RESEARCH INC-CLASS A

NASDAQ:ACMR (6/13/2025, 8:00:00 PM)

After market: 24.3701 0 (0%)

24.37

-1.36 (-5.29%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)05-08 2025-05-08/bmo
Earnings (Next)08-05 2025-08-05/bmo
Inst Owners69.61%
Inst Owner Change1.71%
Ins Owners5.53%
Ins Owner Change0.95%
Market Cap1.56B
Analysts81.43
Price Target35.65 (46.29%)
Short Float %7.43%
Short Ratio2.38
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)32.31%
Min EPS beat(2)22.75%
Max EPS beat(2)41.87%
EPS beat(4)4
Avg EPS beat(4)46.12%
Min EPS beat(4)22.75%
Max EPS beat(4)65.81%
EPS beat(8)8
Avg EPS beat(8)93.35%
EPS beat(12)12
Avg EPS beat(12)967.56%
EPS beat(16)14
Avg EPS beat(16)712.87%
Revenue beat(2)2
Avg Revenue beat(2)7.3%
Min Revenue beat(2)2.19%
Max Revenue beat(2)12.4%
Revenue beat(4)4
Avg Revenue beat(4)10.24%
Min Revenue beat(4)2.19%
Max Revenue beat(4)21.75%
Revenue beat(8)7
Avg Revenue beat(8)9.33%
Revenue beat(12)11
Avg Revenue beat(12)11.86%
Revenue beat(16)12
Avg Revenue beat(16)7.58%
PT rev (1m)-2.15%
PT rev (3m)-2.15%
EPS NQ rev (1m)-2.24%
EPS NQ rev (3m)-4.51%
EPS NY rev (1m)0%
EPS NY rev (3m)9.66%
Revenue NQ rev (1m)1.18%
Revenue NQ rev (3m)0.74%
Revenue NY rev (1m)-0.23%
Revenue NY rev (3m)-0.2%
Valuation
Industry RankSector Rank
PE 11.08
Fwd PE 10.24
P/S 1.94
P/FCF 17.31
P/OCF 9.32
P/B 1.64
P/tB 1.65
EV/EBITDA 7.58
EPS(TTM)2.2
EY9.03%
EPS(NY)2.38
Fwd EY9.77%
FCF(TTM)1.41
FCFY5.78%
OCF(TTM)2.61
OCFY10.73%
SpS12.56
BVpS14.86
TBVpS14.81
PEG (NY)8.37
PEG (5Y)0.26
Profitability
Industry RankSector Rank
ROA 5.48%
ROE 11.17%
ROCE 11.65%
ROIC 9.29%
ROICexc 14.75%
ROICexgc 14.81%
OM 18.95%
PM (TTM) 13.21%
GM 49.23%
FCFM 11.21%
ROA(3y)4.65%
ROA(5y)4.61%
ROE(3y)9.12%
ROE(5y)9.25%
ROIC(3y)7.61%
ROIC(5y)6.62%
ROICexc(3y)11.49%
ROICexc(5y)11.41%
ROICexgc(3y)11.53%
ROICexgc(5y)11.44%
ROCE(3y)9.72%
ROCE(5y)8.55%
ROICexcg growth 3Y8.61%
ROICexcg growth 5Y4.82%
ROICexc growth 3Y8.52%
ROICexc growth 5Y4.78%
OM growth 3Y9.03%
OM growth 5Y3.12%
PM growth 3Y-2.96%
PM growth 5Y-5.43%
GM growth 3Y4.22%
GM growth 5Y1.2%
F-Score5
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 2.52
Debt/EBITDA 0.98
Cap/Depr 735.44%
Cap/Sales 9.6%
Interest Coverage 30.83
Cash Conversion 102.75%
Profit Quality 84.84%
Current Ratio 2.46
Quick Ratio 1.49
Altman-Z 2.42
F-Score5
WACC9.77%
ROIC/WACC0.95
Cap/Depr(3y)1125.53%
Cap/Depr(5y)1046.26%
Cap/Sales(3y)15.42%
Cap/Sales(5y)11.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10%
EPS 3Y52.55%
EPS 5Y42.35%
EPS Q2Q%-11.54%
EPS Next Y1.32%
EPS Next 2Y2.62%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)26.21%
Revenue growth 3Y44.39%
Revenue growth 5Y48.72%
Sales Q2Q%13.24%
Revenue Next Year21.63%
Revenue Next 2Y18.38%
Revenue Next 3Y18.8%
Revenue Next 5Y17.05%
EBIT growth 1Y35.78%
EBIT growth 3Y57.43%
EBIT growth 5Y53.36%
EBIT Next Year10.24%
EBIT Next 3Y13.48%
EBIT Next 5Y13.54%
FCF growth 1Y153.23%
FCF growth 3YN/A
FCF growth 5Y51.5%
OCF growth 1Y357.01%
OCF growth 3YN/A
OCF growth 5Y74.48%